HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis.

AbstractPURPOSE:
We investigated the usefulness of [(99m)Tc]duramycin for monitoring early response to cancer therapy in mice, with an eye towards clinical translation.
PROCEDURES:
[(99m)Tc]Duramycin was injected in healthy CD1-/- mice to estimate human [(99m)Tc]duramycin radiation dose. [(99m)Tc]Duramycin single-photon emission computed tomography (SPECT) imaging of apoptosis was evaluated in a mouse model of colorectal cancer treated with irinotecan and validated ex vivo using autoradiography, cleaved caspase-3, and TdT-mediated dUTP nick-end labeling (TUNEL) histology of the tumors.
RESULTS:
The mean effective dose was estimated to be 3.74 × 10(-3) ± 3.43 × 10(-4) mSv/MBq for non-purified and 3.19 × 10(-3) ± 2.16 × 10(-4) mSv/MBq for purified [(99m)Tc]duramycin. [(99m)Tc]Duramycin uptake in vivo following therapy increased significantly in apoptotic irinotecan-treated tumors (p = 0.008). Radioactivity in the tumors positively correlated with cleaved caspase-3 (r = 0.85, p < 0.001) and TUNEL (r = 0.92, p < 0.001) staining.
CONCLUSION:
[(99m)Tc]Duramycin can be used to detect early chemotherapy-induced tumor cell death, and thus, may be a prospective candidate for clinical SPECT imaging of tumor response to therapy.
AuthorsFilipe Elvas, Christel Vangestel, Sara Rapic, Jeroen Verhaeghe, Brian Gray, Koon Pak, Sigrid Stroobants, Steven Staelens, Leonie Wyffels
JournalMolecular imaging and biology (Mol Imaging Biol) Vol. 17 Issue 6 Pg. 838-47 (Dec 2015) ISSN: 1860-2002 [Electronic] United States
PMID25896815 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
Chemical References
  • Bacteriocins
  • Peptides
  • duramycin
  • Technetium
Topics
  • Animals
  • Apoptosis
  • Bacteriocins (administration & dosage, chemistry, pharmacokinetics)
  • Female
  • Mice
  • Mice, Nude
  • Neoplasms, Experimental (diagnostic imaging, metabolism, pathology)
  • Peptides (administration & dosage, chemistry, pharmacokinetics)
  • Technetium (administration & dosage, chemistry, pharmacokinetics)
  • Tissue Distribution
  • Tomography, Emission-Computed, Single-Photon (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: